Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (241-250 of 275) with videos related to

Pageof 28
Sort By:
Leukemia Research|June 18, 2013
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic deathJessica K Altman, Alfred Rademaker, Elizabeth Cull, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Blood|September 23, 2010
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupMartin S Tallman, Haesook T Kim, Pau Montesinos, et al.
Nature Cancer|April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemiaKoichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.
Nature Genetics|March 16, 2010
PHF6 mutations in T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.
Nature Medicine|October 26, 2010
The TLX1 oncogene drives aneuploidy in T cell transformationKim De Keersmaecker, Pedro J Real, Giusy Della Gatta, et al.
Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
Pageof 28

Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Leukemia Research|June 18, 2013
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic deathJessica K Altman, Alfred Rademaker, Elizabeth Cull, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Blood|September 23, 2010
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupMartin S Tallman, Haesook T Kim, Pau Montesinos, et al.
Nature Cancer|April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemiaKoichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.
Nature Genetics|March 16, 2010
PHF6 mutations in T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.
Nature Medicine|October 26, 2010
The TLX1 oncogene drives aneuploidy in T cell transformationKim De Keersmaecker, Pedro J Real, Giusy Della Gatta, et al.
Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
Pageof 28